Skip to main content

Table 4 Multivariable analysis

From: Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study

Survival

Parameter

Hazard ratio

95 % CI

p value

Event-free

Lack of complete combined metabolic and morphologic remission

2.54

1.84–3.51

<0.005

Expression of CD5

2.99

1.02–9.13

0.047

Progression-free

Lack of complete remission according to international criteria

16.39

4.57–58.82

<0.005

Overall

Expression of FOXP1

5.61

1.34–23.4

0.018

Lack of complete combined metabolic and morphologic remission

1.93

1.04–3.58

0.038

  1. Only significant results are shown